Renard Delphine, Gauthier Thierry, Venetz Jean-Pierre, Buclin Thierry, Kuntzer Thierry
Division of Clinical Pharmacology , University Hospital of Lausanne , Lausanne , Switzerland.
Riviera Hospital , Vevey , Switzerland.
Clin Kidney J. 2012 Aug;5(4):323-6. doi: 10.1093/ckj/sfs067.
A 59-year-old kidney recipient was diagnosed with a late onset of severe chronic inflammatory demyelinating polyradiculoneuropathy and almost fully recovered after stopping tacrolimus and one course of intravenous immunoglobulin treatment. Unique features of this patient are the unusually long time lapse between initiation of tacrolimus and the adverse effect (10 years), a strong causality link and several arguments pointing toward an inflammatory etiology. When facing new neurological signs and symptoms in graft recipients, it is important to bear in mind the possibility of a drug-induced adverse event. Discontinuation of the suspect drug and immunomodulation are useful treatment options.
一名59岁的肾移植受者被诊断为迟发性严重慢性炎症性脱髓鞘性多发性神经根神经病,在停用他克莫司并接受一个疗程的静脉注射免疫球蛋白治疗后几乎完全康复。该患者的独特之处在于他克莫司开始使用与出现不良反应之间的时间间隔异常长(10年),存在很强的因果关系,且有多个证据指向炎症病因。当移植受者出现新的神经症状和体征时,必须牢记药物引起不良事件的可能性。停用可疑药物和进行免疫调节是有用的治疗选择。